OGFRP1 and endometrial cancer: Furthermore, OGFRP1 suppression inhibits the malignant behavior of the endometrial cancer cells (Ishikawa) [22], hepatocellular carcinoma cells (Hep3B) [24], cervical carcinoma cells (C33A and SiHa) [23], gestational choriocarcinoma cells (JEG3) [25] and human coronary artery endothelial cells (HCAECs) [26].